U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
183301183301Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesCompletedNo Results AvailableLife Threatening DiseasesDrug: Imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00154388
183302183302Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive GlioblastomaCompletedHas ResultsGlioblastoma Multiforme|AstrocytomaDrug: Imatinib mesylate|Drug: Hydroxyureahttps://ClinicalTrials.gov/show/NCT00154375
183303183303The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.CompletedNo Results AvailableConduct DisorderDrug: Oxcarbazepinehttps://ClinicalTrials.gov/show/NCT00154362
183304183304Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic LeukemiaCompletedNo Results AvailablePhiladelphia Chromosome Positive Acute Lymphocytic LeukemiaDrug: Imatinib Mesylatehttps://ClinicalTrials.gov/show/NCT00154349
183305183305A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.CompletedNo Results AvailableRheumatoid ArthritisDrug: Imatinib in combination with methotrexatehttps://ClinicalTrials.gov/show/NCT00154336
183306183306The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.CompletedNo Results AvailableBipolar DisorderDrug: Oxcarbazepinehttps://ClinicalTrials.gov/show/NCT00154323
183307183307Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant PatientsCompletedHas ResultsRenal TransplantationDrug: Everolimus|Drug: Cyclosporine|Drug: Enteric-coated mycophenolate sodium|Drug: Corticosteroidshttps://ClinicalTrials.gov/show/NCT00154310
183308183308Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant PatientsCompletedHas ResultsRenal TransplantationDrug: Everolimus (RAD001)https://ClinicalTrials.gov/show/NCT00154297
183309183309Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant PatientsCompletedHas ResultsOrgan Transplantation, Renal TransplantationDrug: Everolimus (Certican)|Drug: Cyclosporine (Neoral)|Drug: Steroid|Drug: Basiliximab (Simulect)https://ClinicalTrials.gov/show/NCT00154284
183310183310Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)CompletedNo Results AvailableHypertensionDrug: Valsartan, Valsartan HCThttps://ClinicalTrials.gov/show/NCT00154271
183311183311A Long Term Study of Clozapine in Patients With Treatment-resistant SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Clozapinehttps://ClinicalTrials.gov/show/NCT00154258
183312183312A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients.CompletedNo Results AvailableKidney TransplantationDrug: Enteric-Coated Mycophenolate sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00154245
183313183313Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)CompletedNo Results AvailableRenal TransplantationDrug: Enteric-Coated Mycophenolate Sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00154232
183314183314Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip OsteoarthritisCompletedNo Results AvailableOsteoarthritis, HipDrug: Lumiracoxib (drug)https://ClinicalTrials.gov/show/NCT00154219
183315183315Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant PatientsCompletedNo Results AvailableKidney TransplantationDrug: Enteric-Coated Mycophenolate Sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00154206
183316183316Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 LevelsCompletedNo Results AvailableHeart and Lung TransplantDrug: cyclosporinehttps://ClinicalTrials.gov/show/NCT00154193
183317183317Kronos Early Estrogen Prevention Study (KEEPS)Active, not recruitingNo Results AvailableMenopause|ArteriosclerosisDrug: Conjugated equine estrogens 0.45 mg/day|Drug: Transdermal estradiol, 50 mcg/day|Drug: Micronized progesterone, 200 mg/day x 12 d/month|Drug: CEE , progesterone, estradiol patch or placebo for each|Drug: CEE, progesterone, transdermal patch or the placebohttps://ClinicalTrials.gov/show/NCT00154180
183318183318Safety and Efficacy Study of NV-101 in Dental PatientsCompletedNo Results AvailableSoft Tissue Anesthesia (Numbness)Drug: NV-101 (phentolamine mesylate solution)https://ClinicalTrials.gov/show/NCT00154167
183319183319Hope for the Chronically Suicidal PatientCompletedNo Results AvailableBorderline Personality DisorderBehavioral: General Psychiatric Management|Behavioral: Dialectical Behaviour Therapyhttps://ClinicalTrials.gov/show/NCT00154154
183320183320Evaluation of Fibrin Sealant 2 in Vascular Surgical ProceduresCompletedNo Results AvailablePeripheral Vascular DiseaseDrug: Fibrin sealant (FS2)https://ClinicalTrials.gov/show/NCT00154141
183321183321The Influence of a Stabilization Splint on the Body PostureCompletedNo Results AvailableTemporomandibular Disorders|Craniomandibular Disorders|Arthromyalgia|Chronic Disease|Occlusal ApplianceDevice: occlusal appliancehttps://ClinicalTrials.gov/show/NCT00154128
183322183322Levosimendan in High Risk Heart Valve SurgeryCompletedNo Results AvailableHeart FailureDrug: levosimendan|Drug: placebohttps://ClinicalTrials.gov/show/NCT00154115
183323183323Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)CompletedHas ResultsEpidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal CancerDrug: Cetuximab|Drug: FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)https://ClinicalTrials.gov/show/NCT00154102
183324183324A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial NeoplasiaCompletedNo Results AvailableCervical Intraepithelial NeoplasiaDrug: EM-1421https://ClinicalTrials.gov/show/NCT00154089
183325183325A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated EpilepsiesCompletedNo Results AvailableEpilepsyDrug: Zonisamide|Drug: Topiramatehttps://ClinicalTrials.gov/show/NCT00154076
183326183326Efficacy and Safety Study of E2007 in Migraine ProphylaxisCompletedHas ResultsMigraine ProphylaxisDrug: E2007|Other: Placebohttps://ClinicalTrials.gov/show/NCT00154063
183327183327High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent AngioplastyCompletedNo Results AvailableArterial Occlusive DiseasesDrug: candesartan (drug) or quinapril (drug)https://ClinicalTrials.gov/show/NCT00154050
183328183328Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.CompletedNo Results AvailableHealthy SubjectsDrug: Pioglitazone (drug) and/or candesartan (drug)https://ClinicalTrials.gov/show/NCT00154037
183329183329Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.CompletedNo Results AvailableHealthy SubjectsDrug: atorvastatin|Drug: irbesartanhttps://ClinicalTrials.gov/show/NCT00154024
183330183330Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.CompletedNo Results AvailableHealthy SubjectsDrug: rosiglitazone (drug)https://ClinicalTrials.gov/show/NCT00154011

* Görseller ve İçerik tekif hakkına sahip olabilir